Roche Chairman Franz B. Humer announces that he will not stand for re-election in 2014
March 5, 2013
Franz B. Humer, Chairman of the Board of Directors of the Roche Group, announced at today’s Annual General Meeting that he will not stand for re-election to the Board in 2014. Roche will nominate a successor for the chairmanship in autumn 2013. The Roche Board has decided that Franz Humer’s successor will also serve as [...]
Promega’s New Trypsin/Lys-C Mix Enhances Proteolysis of Difficult-to-Digest Proteins
March 5, 2013
Madison, WI USA: Promega Corporation announces the launch of Trypsin/Lys-C Mix, Mass Spectrometry Grade. A unique combination of Trypsin Gold and rLys-C proteases, the new mix increases peptide generation with in-solution protein digestion and works with even difficult to digest proteins. Enhanced proteolytic activity achieved through use of Trypsin/Lys-C Mix can result in a 20-40% [...]
Instem Receives Award from National Institute of Environmental Health Sciences
March 4, 2013
CONSHOHOCKEN, PA - Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that The National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes of Health (NIH), has purchased the Provantis® preclinical software suite to support National Toxicology Program studies. These Reproductive, Immunotox, Neurobehavioral, Sensitization and [...]
March 4, 2013
ANN ARBOR, Mich., -- Advanced Photonix® (NYSE MKT: API), a leading supplier of Optoelectronic components, sub-systems and systems to industry, announced today that it has acquired certain assets of Silonex, Inc. Silonex, Inc. is/was a wholly owned subsidiary of ARCAS Automotive Group (Luxco 1) S.a.r.l. , in exchange for a cash payment of $900,000. The [...]
Trovagene Appoints Mark Erlander, Ph.D. as Chief Scientific Officer
March 4, 2013
SAN DIEGO, CA –- Trovagene, Inc. (NASDAQ: TROV), a developer of transrenal molecular diagnostics, today announced that Mark Erlander, Ph.D., has joined the company as chief scientific officer. Dr. Erlander has more than 18 years of experience directing research teams with a strong focus in oncology-based molecular diagnostics. He has developed multiple novel molecular diagnostic [...]
Dako Launches Advanced Staining Platform at Global Pathology Congress
March 4, 2013
GLOSTRUP, Denmark, – Dako, an Agilent Technologies Company and worldwide provider of cancer diagnostics, unveiled the newest addition to its IHC portfolio at the 2013 USCAP congress in Baltimore, Maryland, today. As the exclusive Platinum Sponsor of the congress, Dako used the opportunity to present its new advanced staining solution to a global gathering of [...]
March 4, 2013
Palo Alto, California -- PREMIER Biosoft, a leading provider of software solutions for life science research, today announced the acquisition of ProteoIQ from NuSep a publicly listed Australia firm. With ProteoIQ, PREMIER Biosoft now offers a broad spectrum of products for mass spectrometry based "Omics" and "Imaging" studies to the research community. With this acquisition, [...]
Praxair Features PortaGas™ System and Other Products and Service Innovations at Pittcon
March 4, 2013
DANBURY, Conn., – Praxair, Inc., (NYSE: PX), today announced it will highlight its newly acquired family of portable cylinder products under the PortaGas™ brand at this year’s Pittcon Conference and Expo in Philadelphia, PA, March 17-21. Pittcon is the premier trade event for laboratory science that provides attendees with a first-hand look at the latest [...]
BioTime and Subsidiary LifeMap Sciences Announce Data Mining Collaboration
March 4, 2013
ALAMEDA, Calif.-- BioTime, Inc. (NYSE MKT: BTX) and its bioinformatics subsidiary LifeMap Sciences, Inc. (“LifeMap”) today announced that they have entered into a definitive collaboration agreement to utilize LifeMap’s computer-based tools to extract information relating to novel potential commercial products from nearly 100 million proprietary gene expression data points generated and owned by BioTime. The [...]
Foundation Medicine Receives Accreditation from the College of American Pathologist
March 4, 2013
CAMBRIDGE, Mass., - Foundation Medicine, Inc. today announced that it has received accreditation from the Commission on Laboratory Accreditation of the College of American Pathologists (CAP) based on the results of a recent on-site laboratory inspection. The U.S. federal government recognizes the CAP Laboratory Accreditation Program as being equal-to or more-stringent-than the government’s own inspection [...]
